Similar Papers

Paper Title
Journal
Date
Author
Data from Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer
Fangfang Chen ... Zhiyu Zhang
-
Fangfang Chen, et. al.Fangfang Chen ... Zhiyu Zhang
15 Feb 2024
Data from Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer
Fangfang Chen ... Zhiyu Zhang
-
Fangfang Chen, et. al.Fangfang Chen ... Zhiyu Zhang
15 Feb 2024
Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population
Xiao-Bin Cui ... Feng Li
Gene | VOL. 530
Xiao-Bin Cui, et. al.Xiao-Bin Cui ... Feng Li
24 Aug 2013
MicroRNA-145 suppresses esophageal squamous cell carcinoma by targeting phospholipase C epsilon 1
...
Chinese journal of experimental surgery | VOL. 34
, et. al. ...
08 Sep 2017
View more papers

More From: Cancer research

Paper Title
Journal
Date
Author
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.
Tanvi H Visal ... Sendurai A Mani
Cancer research | VOL. -
Tanvi H Visal, et. al.Tanvi H Visal ... Sendurai A Mani
24 Jan 2025
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.
Ran Chen ... Daming Gao
Cancer research | VOL. -
Ran Chen, et. al.Ran Chen ... Daming Gao
24 Jan 2025
Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival.
Ziwei Guo ... Mo Chen
Cancer research | VOL. -
Ziwei Guo, et. al.Ziwei Guo ... Mo Chen
24 Jan 2025
Comparison of Lean, Obese, and Weight Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T Cell Populations.
Elysa W Pierro ... Alyssa H Hasty
Cancer research | VOL. -
Elysa W Pierro, et. al.Elysa W Pierro ... Alyssa H Hasty
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.